Jisi Yingda

About:

Jisi Yingda is a small-molecule anti-cancer drug developer, in the field of small-molecule tumor immune drugs and tumor drug development.

Website: http://www.jsinnopharm.com/

Top Investors: Oriental Fortune Capital, Suzhou International Development Venture Capital, Baidu Ventures, Zhidao Capital, Jiuyou Capital

Description:

Jisi Yingda is a small-molecule anti-cancer drug developer, in the field of small-molecule tumor immune drugs and tumor drug development.

Total Funding Amount:

100M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2010-11-01

Contact Email:

contact(AT)jsinnopharm.com

Founders:

Jintao Zhang

Number of Employees:

11-50

Last Funding Date:

2021-11-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai